| Drug Name: | Becaplermin (165101-51-9) |
|---|---|
| PubChem ID: | 124081046 |
| SMILES: | C[C@H]1CC[C@@H](O[C@H]1[C@H](C)C(=O)O)C[C@@H]2C[C@@H]([C@H]([C@@]3(O2)[C@H](C[C@@](O3)(C)[C@H]4CC[C@](O4)(C)[C@H]5[C@H](C[C@@H](O5)[C@@H]6[C@H](C[C@H]([C@@](O6)(CO)O)C)C)C)C)C)OC |
| InchiKey: | DANUORFCFTYTSZ-VSJJYQSHSA-N |
| Therapeutic Category: | Angiogenesis Inducing Agents, Angiogenesis Modulating Agents, Growth Substances |
| Molecular Weight (dalton) | : | 724.973 |
| LogP | : | 5.7056 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 10 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 142.37 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Application Site Burning | ADReCS |
| Erythema | ADReCS |
| Neoplasm Malignant | ADReCS |
| Rash Erythematous | ADReCS |